AquaBounty Technologies, Inc. (LON:ABTU) Files An 8-K Material Modification to Rights of Security HoldersITEM 3.03.
As previously disclosed in Exhibit 99.1 to its Registration Statement on Form 10, as first filed with the Securities and Exchange Commission on November 7, 2016, AquaBounty Technologies, Inc. (“AquaBounty”) and Intrexon Corporation (“Intrexon”), AquaBounty’s majority shareholder, entered into a stock purchase agreement (“Purchase Agreement”) on November 7, 2016, to which AquaBounty agreed to sell to Intrexon $25 million in shares of AquaBounty’s common stock, par value $0.001 (“Common Stock”). On January 18, 2017, AquaBounty issued 2,421,073 shares of Common Stock to Intrexon under the terms of the Purchase Agreement. AquaBounty issued the shares of Common Stock to Intrexon to the exemption from registration afforded by Section 4(a)(2) of the Securities Act of 1933 or Regulation D thereunder.
About AquaBounty Technologies, Inc. (LON:ABTU)
AquaBounty Technologies, Inc. is a biotechnology company engaged in research, development and commercialization of the commercial viability of a group of proteins, antifreeze proteins (AFPs). The Company focuses on the managing aquaculture productivity. It offers AquAdvantage Salmon (AAS), which can be grown in contained, land-based facilities. It offers AquAdvantage Salmon for land-based facilities that can be built closer to consumers to manage the need for air freight shipping and transportation. The Company’s subsidiaries include AquaBounty Canada, Inc., which operates a commercial biotechnology laboratory that conducts research and development programs related to the Company’s technologies; AquaBounty Panama, S. de R.L.; AquaBounty Farms, Inc., and AquaBounty Brasil Participacoes Ltda., which conducts commercial trials of the Company’s AquAdvantage Salmon. AquaBounty Technologies, Inc. (LON:ABTU) Recent Trading Information
AquaBounty Technologies, Inc. (LON:ABTU) closed its last trading session down -267.50 at 1,250.00 with 0 shares trading hands.
